Table of contents
January 2007 Volume 3 No 1
Editorial
Viewpoint
Strategies for therapy in acute ischemic stroke
2In this Viewpoint article, Alastair Buchan and James Kennedy evaluate emerging options for the treatment of acute ischemic stroke and discuss the difficulties associated with choosing the patients who might benefit most from them.
Research Highlights
Statins improve endothelial function in patients with lacunar infarctions
4New evidence-based guidelines for the management of transient ischemic attack
4Increased cortical excitability could induce epileptic seizures after sleep deprivation
4Abnormal gait function could be used to screen for autism
5Treatment-resistant depression responds to repetitive transcranial magnetic stimulation
6A mutant lysosomal ATPase causes hereditary parkinsonism
6Herpes simplex virus-1 associates with changes in brain morphology in schizophrenia
6High-dose EPO improves cognitive function in chronic schizophrenia
7Ubiquitinated TDP-43 is associated with FTLD and ALS
7Fingolimod shows therapeutic potential for relapsing multiple sclerosis
8Sleep-related breathing disorder increases the risk of developing depression
8Delayed carotid endarterectomy recommended for patients with completed stroke
9Practice Points
Headache in the emergency department—how to identify patients at risk of serious underlying pathology
10Is there a link between aspirin therapy and stroke severity?
12Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy?
14Complex regional pain syndrome—are we neglecting neglect?
16Do all patients with Duchenne muscular dystrophy require surgery for the correction of scoliosis?
18Do poststroke MRI findings predict the type of a subsequent stroke?
20Reviews
Primary CNS lymphoma
24Primary CNS lymphoma, an extranodal non-Hodgkin's lymphoma that invades the nervous system, accounts for around 3% of all primary brain tumors. In this Review, Hochberg et al. highlight recent advances in our understanding of the pathogenesis of primary CNS lymphoma, and they discuss current approaches to the diagnosis and therapy of this condition.
doi:10.1038/ncpneuro0395 | Full Text | PDF (661K)
Drug Insight: the use of intravenous immunoglobulin in neurology—therapeutic considerations and practical issues
36Intravenous immunoglobulin has an important role in the treatment of numerous neuroimmunological disorders, including Guillain–Barré syndrome and multiple sclerosis. In this article, Gold et al. review current and future indications for intravenous immunoglobulin treatment, discuss its proposed mechanisms of action, and highlight various practical issues relating to its use in the clinic.
doi:10.1038/ncpneuro0376 | Full Text | PDF (228K)
Technology Insight: recanalization with drugs and devices during acute ischemic stroke
45Revascularization has a pivotal role in ischemic stroke therapy, and strokes involving small blood vessels respond well to intravenously administered thrombolytic drugs. Large-vessel strokes carry higher morbidity and mortality than small-vessel strokes, and are less amenable to thrombolytic approaches. In this Review, Wade Smith assesses recent data indicating that recanalization of large vessels can be achieved using mechanical clot retrieval devices.
doi:10.1038/ncpneuro0372 | Full Text | PDF (334K)
Case Study

Superficial siderosis: a case report and review of the literature
54doi:10.1038/ncpneuro0356 | Full Text | PDF (417K)

